P
Philippe Rousselot
Researcher at Centre national de la recherche scientifique
Publications - 267
Citations - 9783
Philippe Rousselot is an academic researcher from Centre national de la recherche scientifique. The author has contributed to research in topics: Imatinib mesylate & Myeloid leukemia. The author has an hindex of 48, co-authored 266 publications receiving 8559 citations. Previous affiliations of Philippe Rousselot include University of Franche-Comté.
Papers
More filters
Journal ArticleDOI
The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts
Camille N. Abboud,Ellin Berman,Adam D. Cohen,Jorge E. Cortes,Daniel J. DeAngelo,Michael W. Deininger,Steven M. Devine,Brian J. Druker,Amir T. Fathi,Elias Jabbour,Madan Jagasia,Hagop M. Kantarjian,Jean Khoury,Pierre Laneuville,Richard A. Larson,Jeffrey H. Lipton,Joseph O. Moore,Tariq I. Mughal,Susan O'Brien,Javier Pinilla-Ibarz,Alfonso Quintás-Cardama,Jerald P. Radich,Vishnu Reddy,Charles A. Schiffer,Neil P. Shah,Paul J. Shami,Richard T. Silver,David S. Snyder,Richard Stone,Moshe Talpaz,Ayalew Tefferi,Richard A. Van Etten,Meir Wetzler,Elisabetta Abruzzese,Jane F. Apperley,Massimo Breccia,Jenny Byrne,Francisco Cervantes,Ekaterina Chelysheva,Richard E. Clark,Hugues de Lavallade,Iryna Dyagil,Carlo Gambacorti-Passerini,John M. Goldman,Ibrahim C. Haznedaroglu,Henrik Hjorth-Hansen,Tessa L. Holyoake,Brian J. P. Huntly,Philipp le Coutre,Elza Lomaia,Francois-Xavier Mahon,David Marin-Costa,Giovanni Martinelli,Jiri Mayer,Dragana Milojkovic,Eduardo Olavarria,Kimmo Porkka,Johan Richter,Philippe Rousselot,Giuseppe Saglio,Güray Saydam,Jesper Stentoft,Anna G. Turkina,Paolo Vigneri,Andrey Zaritskey,Alvaro Aguayo,Manuel Ayala,Israel Bendit,Raquel Bengió,Carlos Best,Eduardo Bullorsky,Eduardo Cervera,Carmino DeSouza,Ernesto Fanilla,David Gómez-Almaguer,Nelson Hamerschlak,José A. López,Alicia Magarinos,Luis Meillon,Jorge Milone,Beatriz Moiraghi,Ricardo Pasquini,Carolina Pavlovsky,Guillermo J. Ruiz-Argüelles,Nelson Spector,Christopher Arthur,Peter Browett,Andrew Grigg,Jianda Hu,Xiao-Jun Huang,Timothy P. Hughes,Qian Jiang,Saengsuree Jootar,Dong-Wook Kim,Hemant Malhotra,Pankaj Malhotra,Itaru Matsumura,Junia V. Melo,Kazunori Ohnishi,Ryuzo Ohno,Tapan Saikia,Anthony P. Schwarer,Naoto Takahashi,Constantine S. Tam,Tetsuzo Tauchi,Kensuke Usuki,Jianxiang Wang,Fawzi Abdel-Rahman,Mahmoud Aljurf,Ali Bazarbachi,Dina Ben Yehuda,Naeem Chaudhri,Muheez A. Durosinmi,Hossam Kamel,Vernon J. Louw,Bassam Francis Matti,Arnon Nagler,Pia Raanani,Ziad Salem +118 more
TL;DR: There is a need to (1) lower the prices of cancer drugs to allow more patients to afford them and (2) maintain sound long-term health care policies.
Journal ArticleDOI
Loss of Major Molecular Response As a Trigger for Restarting Tyrosine Kinase Inhibitor Therapy in Patients With Chronic-Phase Chronic Myelogenous Leukemia Who Have Stopped Imatinib After Durable Undetectable Disease
Philippe Rousselot,Aude Charbonnier,Pascale Cony-Makhoul,Philippe Agape,Franck E. Nicolini,Bruno Varet,Martine Gardembas,Gabriel Etienne,Delphine Rea,Lydia Roy,Martine Escoffre-Barbe,Agnès Guerci-Bresler,Michel Tulliez,Stéphane Prost,Marc Spentchian,Jean Michel Cayuela,Josy Reiffers,Jean-Claude Chomel,Ali G. Turhan,Joelle Guilhot,François Guilhot,Francois-Xavier Mahon +21 more
TL;DR: Loss of MMR is a practical and safe criterion for restarting therapy in patients with CML with prolonged CMR, and should be a criterion for resuming therapy.
Journal ArticleDOI
The canada-france ecliptic plane survey—full data release: the orbital structure of the kuiper belt*
Jean-Marc Petit,Jean-Marc Petit,Jj Kavelaars,Brett Gladman,R. L. Jones,R. L. Jones,J. Wm. Parker,C. Van Laerhoven,C. Van Laerhoven,P. D. Nicholson,G. Mars,Philippe Rousselot,Olivier Mousis,Brian G. Marsden,Allyson Bieryla,Matthew J. Taylor,M. L. N. Ashby,Paula Gabriela Benavídez,A. Campo Bagatin,Guillermo Bernabeu +19 more
TL;DR: In this paper, the authors report the orbital distribution of the trans-Neptunian objects (TNOs) discovered during the Canada-France Ecliptic Plane Survey (CFEPS), whose discovery phase ran from early 2003 until early 2007.
Journal ArticleDOI
BCR-ABL1 compound mutations combining key kinase domain positions confer clinical resistance to ponatinib in Ph chromosome-positive leukemia.
Matthew S. Zabriskie,Christopher A. Eide,Christopher A. Eide,Srinivas K. Tantravahi,Nadeem A. Vellore,Johanna Estrada,Franck E. Nicolini,Hanna Jean Khoury,Richard A. Larson,Marina Konopleva,Jorge E. Cortes,Hagop M. Kantarjian,Elias J. Jabbour,Steven M. Kornblau,Jeffrey H. Lipton,Delphine Rea,Leif Stenke,Gisela Barbany,Thoralf Lange,Juan Carlos Hernández-Boluda,Gert J. Ossenkoppele,Richard D. Press,Charles Chuah,Stuart L. Goldberg,Meir Wetzler,François Xavier Mahon,Gabriel Etienne,Michele Baccarani,Simona Soverini,Gianantonio Rosti,Philippe Rousselot,Ran Friedman,Marie Deininger,Kimberly R. Reynolds,William L. Heaton,Anna M. Eiring,Anthony D. Pomicter,Jamshid S. Khorashad,Todd W. Kelley,Riccardo Baron,Brian J. Druker,Brian J. Druker,Michael W. Deininger,Thomas O'Hare +43 more
TL;DR: These findings demonstrate that BCR-ABL1 compound mutants confer different levels of TKI resistance, necessitating rational treatment selection to optimize clinical outcome, and in vitro resistance profiling was predictive of treatment outcomes in Ph(+) leukemia patients.
Journal ArticleDOI
The Canada-France Ecliptic Plane Survey - Full Data Release: The orbital structure of the Kuiper belt
Jean-Marc Petit,Jj Kavelaars,Brett Gladman,R. Lynne Jones,Joel Wm. Parker,Christa Van Laerhoven,Phil D. Nicholson,Gilbert Mars,Philippe Rousselot,Olivier Mousis,Brian G. Marsden,Allyson Bieryla,Matthew J. Taylor,Matthew L.N. Ashby,Paula Gabriela Benavídez,Adriano Campo Bagatin,Guillermo Bernabeu +16 more
TL;DR: In this article, the authors report the orbital distribution of the trans-neptunian objects (TNOs) discovered during the Canada-France Ecliptic Plane Survey, whose discovery phase ran from early 2003 until early 2007.